Literature DB >> 3787687

Inhibition in vivo of both infective Leishmania major and L. mexicana amazonensis mediated by a single monoclonal antibody.

M C Debons-Guillemin, I Vouldoukis, A Roseto, C Alfred, C Chopin, I Ploton, L Monjour.   

Abstract

Monoclonal antibodies raised against a strain of Leishmania infantum isolated in Greece were produced and tested for their protective effect in an in vivo system (in BALB/C mice). A single monoclonal antibody, IgG2b isotype, can prevent the development of two Leishmania strains in vivo: one of L. major and one of L. mexicana amazonensis. This antibody-mediated protection may be dependent on complement.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3787687      PMCID： PMC7107255          DOI： 10.1016/0035-9203(86)90030-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


  13 in total

1.  Alterations of the immune response associated with chronic experimental leishmaniasis.

Authors:  B Arredondo; H Pérez
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  [Use of counterimmunoelectrophoresis on cellulose acetate membrane for the diagnosis of human and animal visceral leishmaniasis].

Authors:  L Monjour; C Mille; P Druilhe; M Gentilini
Journal:  Ann Soc Belg Med Trop       Date:  1978-12

3.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

4.  Leishmania mexicana and Leishmania tropica major: adoptive transfer of immunity in mice.

Authors:  J Alexander; R S Phillips
Journal:  Exp Parasitol       Date:  1980-02       Impact factor: 2.011

5.  Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis.

Authors:  D McMahon-Pratt; E Bennett; J R David
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

7.  Rapid, large-scale production and isolation for Leishmania amastigotes.

Authors:  L Monjour; I Vouldoukis; O Brandicourt; D Mazier; C Alfred; I Ploton; M Gentilini
Journal:  Ann Trop Med Parasitol       Date:  1984-08

8.  Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.

Authors:  J G Howard; S Nicklin; C Hale; F Y Liew
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

9.  Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by monoclonal antibodies.

Authors:  E Handman; R E Hocking
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  [Isolation of cell hybrids secreting specific antibodies against bovine enteric coronavirus (author's transl)].

Authors:  A Roseto; J F Vautherot; P Bobulesco; M C Guillemin
Journal:  C R Seances Acad Sci III       Date:  1982-02-22
View more
  3 in total

1.  Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice.

Authors:  D Frommel; B W Ogunkolade; I Vouldoukis; L Monjour
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

3.  Comment on "Regulation of immunity during visceral Leishmania infection" and further discussions about the role of antibodies in infections with Leishmania.

Authors:  Luiz Gustavo Gardinassi; Isabel Kinney Ferreira de Miranda Santos
Journal:  Parasit Vectors       Date:  2016-07-07       Impact factor: 3.876
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.